Pacira ended the third quarter of 2024 with cash, cash equivalents and available-for-sale investments (“cash”) of $453.8 million. Cash provided by operations was $53.9 million in the third quarter of ...
Stressed out over the election? While many turn to recreational cannabis to help relax, it is important to be informed before walking in to a Connecticut dispensary for the first time. It can be ...
Investment analysts at Leerink Partnrs cut their Q4 2024 earnings estimates for Bristol-Myers Squibb in a research report issued on Monday, November 4th. Leerink Partnrs analyst D. Risinger now ...